Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (17)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Koh, W.-J.
Right arrow Articles by Kim, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koh, W.-J.
Right arrow Articles by Kim, J. W.
(Chest. 2005;128:94-101.)
© 2005 American College of Chest Physicians

NRAMP1 Gene Polymorphism and Susceptibility to Nontuberculous Mycobacterial Lung Diseases*

Won-Jung Koh, MD; O. Jung Kwon, MD; Eun Joo Kim, PhD; Kyung Soo Lee, MD; Chang-Seok Ki, MD and Jong Won Kim, MD

* From the Division of Pulmonary and Critical Care Medicine, Departments of Medicine (Drs. Koh, Kwon, and E.J. Kim), Radiology (Dr. Lee), and Laboratory Medicine (Drs. Ki, and J.W. Kim), Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Correspondence to: O. Jung Kwon, MD, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, 50 Irwon-Dong, Gangnam-gu, Seoul 135–710, South Korea; e-mail: ojkwon{at}smc.samsung.co.kr

Study objectives: Pulmonary disease caused by nontuberculous mycobacteria (NTM) may occur in patients with no underlying lung disease and no known immunodeficiency. The purpose of this study was to evaluate a potential role for natural-resistance-associated macrophage protein 1 (NRAMP1) gene polymorphisms for human susceptibility to the NTM lung disease.

Design: A case-control study.

Setting: Tertiary university medical center.

Participants: Forty-one adult patients with NTM lung disease (Mycobacterium avium complex infection, 18 patients; Mycobacterium abscessus infection, 23 patients) were included in the study population. The diagnosis of NTM lung disease was made when the patients fulfilled the diagnostic criteria published by the American Thoracic Society. All patients had findings on high-resolution CT scans, such as bilateral bronchiectasis combined with multiple small nodules and branching linear structures, that were characteristic of the nodular bronchiectatic form of NTM lung disease. Fifty healthy individuals were selected as control subjects.

Results: Heterozygotes at intron 4 (469 + 14G/C) [INT4], codon 543 in exon 15 (D543N), and 3' untranslated region (3'UTR) were observed at significantly higher frequencies in patients with NTM lung disease than in control subjects. The odds ratios (ORs) were 2.78 (95% confidence interval [CI], 1.12 to 6.89; p = 0.026) for INT4 G/C, 5.74 (95% CI, 1.48 to 22.30; p = 0.006) for D543 G/A, and 9.54 (95% CI, 2.49 to 36.53; p < 0.001) for 3'UTR TGTG+/del. Subjects who were heterozygous for two NRAMP1 polymorphisms in INT4 and D543N were particularly overrepresented among those with NTM lung disease, compared with those with the most common NRAMP1 genotype (OR, 10.88, 95% CI, 1.18 to 100.45; p = 0.035). There were no significant differences in the frequencies of INT4, D543N, and 3'UTR polymorphisms between the patients with M avium complex infection and those with M abscessus infection.

Conclusions: These findings suggest that the NRAMP1 genetic polymorphisms are associated with human susceptibility to NTM lung disease.

Key Words: atypical mycobacteria • cation transport proteins • genetic predisposition to disease • lung diseases • polymorphism




This article has been cited by other articles:


Home page
ChestHome page
J. Glassroth
Pulmonary Disease Due to Nontuberculous Mycobacteria
Chest, January 1, 2008; 133(1): 243 - 251.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W.-J. Koh, J. H. Lee, Y. S. Kwon, K. S. Lee, G. Y. Suh, M. P. Chung, H. Kim, and O. J. Kwon
Prevalence of Gastroesophageal Reflux Disease in Patients With Nontuberculous Mycobacterial Lung Disease
Chest, June 1, 2007; 131(6): 1825 - 1830.
[Abstract] [Full Text] [PDF]


Home page
CVIHome page
Y. J. Ryu, E. J. Kim, W.-J. Koh, H. Kim, O J. Kwon, and J. H. Chang
Toll-Like Receptor 2 Polymorphisms and Nontuberculous Mycobacterial Lung Diseases.
Clin. Vaccine Immunol., July 1, 2006; 13(7): 818 - 819.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
W.-J. Koh, O. J. Kwon, K. Jeon, T. S. Kim, K. S. Lee, Y. K. Park, and G. H. Bai
Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea.
Chest, February 1, 2006; 129(2): 341 - 348.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American College of Chest Physicians.